RVL Pharmaceuticals PLC (NASDAQ:RVLP)
| 1.10 Delayed Data As of 3:59pm ET |  0.00 / 0.00%Today’s Change | 0.99 Today|||52-Week Range 2.99 | -1.79% Year-to-Date |
Latest RVLP News | Press Releases
No recent news for RVL Pharmaceuticals PLC.
Today’s Trading
| Previous close | 1.10 |
| Today’s open | 1.11 |
| Day’s range | 1.07 - 1.16 |
| Volume | 2,640 |
| Average volume (3 months) | 58,265 |
| Market cap | $123.9M |
Data as of 3:59pm ET, 03/22/2023
Growth & Valuation
| Earnings growth (last year) | +21.95% |
| Earnings growth (this year) | +54.43% |
| Earnings growth (next 5 years) | +62.20% |
| Revenue growth (last year) | -90.16% |
| P/E ratio | NM |
| Price/Sales | 4.16 |
| Price/Book | 1.36 |
Competitors
| ---- | ||
| GMDAGamida Cell Ltd | -0.13 | -8.78% |
| TRVITrevi Therapeutics I... | -0.04 | -2.17% |
| MDWDMediwound Ltd | +0.41 | +3.60% |
Data as of 3:59pm ET, 03/22/2023
Financials
| Next reporting date | May 11, 2023 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $17.5M |
| Annual profit (last year) | -$69.0M |
| Net profit margin | -473.40% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bridgewater, New Jersey |
Forecasts
